Death of PC12 cells and hippocampal neurons induced by adenoviral- mediated FAD human amyloid precursor protein gene expression

Journal of Neuroscience Research

Volumn 55, Issue 5, 1999, Pages 629-642

  Luo, Jin Jun ^a,b   Wallace, William ^a   Riccioni, Teresa ^a   Ingram, Donald K ^a   Roth, George S ^a   Kusiak, John W ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Alzheimer's disease; Cell culture; Cell death; Gene transfer; Neurodegeneration

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA GALACTOSIDASE; FLAVINE ADENINE NUCLEOTIDE; VIRUS VECTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; GENE TRANSFER; HIPPOCAMPUS; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; VIRUS INFECTION;

ADENOVIRIDAE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL COUNT; CELL DEATH; CELLS, CULTURED; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HIPPOCAMPUS; MUTATION; NEURONS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RNA, MESSENGER; TIME FACTORS;

EID: 0033104420     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990301)55:5<629::AID-JNR10>3.0.CO;2-Y     Document Type: Article

References (93)

1. Allinquant B, Hantraye P, Mailleux P, Moya K, Bouillot C, Prochiantz A. 1995. Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol 128:919-927.
2. Araki W, Kitaguchi N, Tokushima Y, Ishii K, Aratake H, Shimohama S, Nakamura S, Kimura J. 1991. Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. Biochem Biophys Res Commun 181:265-271.
3. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. 1993. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 3:229-234.
4. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB. 1994. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161-189.
5. Beyreuther K, Bush AI, Dyrks T, Hilbich C, Könning U, Multhaup G, Prior R, Rumble B, Schubert W, Small DH, Weidemann A, Masters CL. 1991. Mechanisms of amyloid deposition in Alzheimer's disease. Ann NY Acad Sci 640:129-139.
6. Blanc EM, Toborek M, Mark RJ, Henning B, Mattson MP. 1997. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 68:1870-1881.
7. Breakefield XO. 1993. Gene delivery into the brain using virus vectors. Nat Genet 3:187-189.
8. Busciglio J, Yeh J, Yankner BA. 1993. β-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem 61:1565-1568.
9. Bush AI, Beyreuther K, Masters CL. 1992. Beta A4 amyloid protein and its precursor in Alzheimer's disease. Pharmacol Ther 56:97-117.
10. Butcher LL, Woolf NJ. 1989. Neurotrophic agents may exacerbate the pathologic cascade of Alzheimer's disease. Neurobiol Aging 10:557-570.
11. Cai X-D, Golde TE, Younkin SG. 1993. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514-516.
12. Carlson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, Eckman C, Meiners J, Nilsen SP, Younkin SG, Hsiao KK. 1997. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 6:1951-1959.
13. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. 1997. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838-841.
14. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ. 1992. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-679.
15. Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnson J, Winblad B, Venizelos N, Lannfelt L, Selkoe DJ. 1994. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Sedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA 91:11993-11997.
16. Clarris HJ, Nurcombe V, Small DH, Beyreuther K, Masters CL. 1994. Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants. J Neurosci Res 38:248-258.
17. Cordell B, Higgins L. 1994. A transgenic mouse model of Alzheimer's disease. In: Masters CL, Beyreuther K, Trillet M, Christen Y, editors. Amyloid protein precursor in development, aging and Alzheimer's disease. Berlin: Springer-Verlag. p 144-145.
18. Cosgaya JM, Latasa MJ, Pascual A. 1996. Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells. J Neurochem 67:98-104.
19. Cotman CW, Pike CJ, Copani A. 1992. β-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol Aging 13:587-590.
20. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. 1993. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 3:219-223.
21. Davidson BL, Doran SE, Shewach DS, Latta JM, Hartman JW, Roessler BJ. 1994. Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp Neurol 125: 258-267.
22. Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, Beyreuther K. 1988. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J 7:949-957.
23. Frade JM, Rodríguez-Tébar, Barde Y-A. 1996. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383:166-168.
24. Frautschy SA, Yang F, Calderon L, Cole GM. 1996. Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits. Neurobiol Aging 17:311-321.
25. Fukuchi K, Ogburn CE, Smith AC, Kunkel DD, Furlong CE, Deeb SS, Nochlin D, Sumi SM, Martin GM. 1993. Transgenic animal models for Alzheimer's disease. Ann NY Acad Sci 695:217-223.
26. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Sorlano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527.
27. Gilman S. 1996. Alzheimer's disease. Perspect Biol Med 40:230-245.
28. Graham FL, Prevec L. 1991. Manipulation of adenovirus vectors. In: Murray EJ, editor. Methods in molecular biology. Volume 7, gene transfer and expression protoclos. Clifton, NJ: Humana Press Inc. p 109-128.
29. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74.
30. Greenburg BD, Savage MJ, Howland DS, Ali SM, Siedlak SL, Perry G, Siman R, Scott RW. 1996. APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol Aging 17:153-171.
31. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. 1992. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357:500-503.
32. Hardy J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159.
33. Haring R, Gurwitz D, Barg J, Pinkas-Kramarski R, Heldman E, Pittel Z, Danenberg HD, Wengier A, Meshulam H, Marciano D, Karton Y, Fisher A. 1995. NGF promotes amyloid precursor protein secretion via muscarinic receptor activation. Biochem Biophys Res Commun 213:15-23.
34. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67:277-286.
35. Horellou P, Mallet J. 1997. Gene therapy for Parkinson's disease. Mol Neurobiol 15:241-256.
36. Horellou P, Vigne E, Castel MN, Barneoud P, Colin P, Perricaudet M, Delaere P, Mallet J. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 6:49-53.
37. Hoyer S. 1994. Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity. Life Sci 55:1977-1983.
38. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits. Aβ elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
39. Ikari H, Zhang L, Chernak JM, Mastrangeli A, Kato S, Kuo H, Crystal RG, Ingram DK, Roth GS. 1995. Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum. Brain Res Mol Brain Res 34:315-320.
40. Itoh A, Nitta A, Nadai M, Nishimura K, Hirose M, Hasegawa T, Nabeshima T. 1996. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein-infused rats. J Neurochem 66:1113-1137.
41. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS. 1995. The toxicity in vitro of beta-amyloid protein. Biochem J 311:1-16.
42. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. 1994. Visualization of A beta 42(43): and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45-53.
43. Jarrett JT, Berger EP, Lansbury PT Jr. 1993. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
44. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94:1550-1555.
45. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S. 1995. Suppression of mitochondrial succinate dehydrogenase, a primary target of β amyloid, and its derivative racemized at ser residue. J Neurochem 65:2585-2593.
46. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Müller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
47. Koh J-Y, Yang LL, Cotman CW. 1990. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 333:315-320.
48. Kozarsky KF, Wilson JM. 1993. Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3:499-503.
49. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G. 1995. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 9:21-30.
50. Lahiri DK, Nall C. 1995. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Brain Res Mol Brain Res 32:233-240.
51. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abetal-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453.
52. Lannfelt L, Folkesson R, Mohammed AH, Winblad B, Hellgren D, Duff K, Hardy J. 1993. Alzheimer's disease: molecular genetics and transgenic animal models. Behav Brain Res 57:207-213.
53. LeBlanc AC, Kovacs DM, Chen HY, Villare F, Tykocinski M, Autilio-Gambetti L, Gambetti P. 1992. Role of amyloid precursor protein (APP): study with antisense transfection of human neuroblastoma cells. J Neurosci Res 31:635-645.
54. Majocha RE, Agrawal S, Tang JY, Humke EW, Marotta CA. 1994. Modulation of the PC12 cell response to nerve growth factor by antisense oligonucleotide to amyloid precursor protein. Cell Mol Neurobiol 14:425-437.
55. Malouf AT. 1992. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging 13:543-551.
56. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. 1997. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054.
57. 717 of amyloid precursor protein are specific for the increased secretion of Aβ42(43). Biochem Biophysic Res Commun 227:730-735.
58. Mattson MP. 1997. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081-1132.
59. McPhie DL, Lee RKK, Eckman CB, Olstein DH, Durham S, Yager D, Younkin SG, Wurtman RJ, Neve RL. 1997. Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains. J Biol Chem 272:24743-24746.
60. Mori H, Takio K, Ogawara M, Selkoe DJ. 1992. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem 267:17028-17086.
61. Neve RL, Boyce FM, McPhie DL, Greenan J, Oster-Granite ML. 1996. Transgenic mice expressing APP-C100 in the brain. Neurobiol Aging 17:191-203.
62. Nishimura I, Uetsuki T, Dani SU, Ohsawa Y, Saito I, Okamura H, Uchiyama Y, Yoshikawa K. 1998. Degeneration in vivo of rat hippocampal neurons by wild type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J Neurosci 18:2387-2398.
63. Oster-Granite ML, McPhie DL, Greenan J, Neve RL. 1996. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci 16:6732-6741.
64. Perez RG, Zheng H, Van der Ploeg LH, Koo EH. 1997. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J Neurosci 17:9407-9414.
65. Price DL, Sisodia SS. 1998. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21:479-505.
66. Price DL, Lamb BT, Gearhart JD, Martin LJ, Walker LC, Koo EH, Borchelt DR, Sisodia SS. 1994. Amyloid in Alzheimer's disease and animal model. In: Masters CL, Beyreuther K, Trillet M, Christen Y, editors. Amyloid protein precursor in development, aging and Alzheimer's disease. Berlin: Springer-Verlag. p 156-168.
67. Price DL, Sisodia SS, Gandy SE. 1995. Amyloid beta amyloidosis in Alzheimer's disease. Curr Opin Neurol 8:268-274.
68. Quon D, Catalano R, Cordell B. 1990. Fibroblast growth factor induces β-amyloid precursor mRNA in glia but not neuronal cultured cells. Biochem Biophys Res Commun 167:96-102.
69. Refolo LM, Salton SRJ, Anderson JP, Mehta P, Robakis NK. 1989. Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem Biophys Res Commun 164:664-670.
70. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Pääkkö PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, Jallat S, Pavirani A, Lecocq J-P, Crystal RG. 1991. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 25:431-434.
71. Sallenave JM, Xing Z, Simpson AJ, Graham FL, Gauldie J. 1998. Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters. Gene Ther 5:352-360.
72. Sandhu FA, Kim Y, Lapan KA, Salim M, Aliuddin V, Zain SB. 1996. Expression of the C terminus of the amyloid precursor protein alters growth factor responsiveness in stably transfected PC12 cells. Proc Natl Acad Sci USA 93:2180-2185.
73. Schmitt TL, Steiner E, Klinger P, Sztankay A, Grubeck-Loebenstein B. 1996. The production of an amyloidogenic metabolite of the Alzheimer amyloid beta precursor protein (APP): in thyroid cells is stimulated by interleukin 1 beta, but inhibited by interferon gamma. J Clin Endocrinol Metab 81:1666-1669.
74. Selkoe DJ. 1993. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci 16:403-409.
75. Selkoe DJ. 1996. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298.
76. Shearman MS, Ragan CI, Iversen LL. 1994. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 91:1470-1474.
77. Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH. 1988. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J 7:1365-1370.
78. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberbur I, Becker GW, Brems DN, Li WY. 1994. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373-379.
79. Slack BE, Breu J, Muchnicki L, Wurtman RJ. 1997. Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C. Biochem J 327:245-249.
80. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
81. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos Jr. L, Eckman C, Golde TE, Younkin SG. 1994. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264:1336-1340.
82. Tamaoka A, Odaka A, Ishibashi Y, Usami M, Sahara N, Suzuki N, Nukina N, Mizusawa H, Shoji S, Kanazawa I, Mori H. 1994. APP717 missense mutation affects the ratio of amyloid β protein species (Aβ1-42/43 and Aβ1-40) in familial Alzheimer's disease brain. J Biol Chem 269:32721-32724.
83. Wallace WC, Lieberburg I, Schenk D, Vigo-Pelfrey C, Davis KL, Haroutunian V. 1995. Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J Neurosci 15:4896-4905.
84. Wallace WC, Akar CA, Lyons WE. 1997a. Amyloid precursor protein potentiates the neurotrophic activity of NGF. Brain Res Mol Brain Res 52:201-212.
85. Wallace WC, Akar CA, Lyons WE, Kole HK, Egan JM, Wolozin B. 1997b. Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Brain Res Mol Brain Res 52:213-227.
86. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacana E, Sunderland T, Zhao B, Kusiak JW, Wasco W, D'Adamio L. 1996. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274:1710-1713.
87. Yamaguchi F, Richards S-J, Beyreuther K, Salbaum M, Carlson GA, Dunnett SB. 1991. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. NeuroReport 2:781-784.
88. Yamamoto K, Miyoshi T, Yae T, Kawashima K, Araki H, Hanada K, Otero DA, Roch JM, Saitoh T. 1994. The survival of rat cerebral cortical neurons in the presence of trophic APP peptides. J Neurobiol 25:585-594.
89. Yamatsuji T, Okamoto T, Takeda S, Murayama Y, Tanaka N, Nishimoto I. 1996. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J 15:498-509.
90. Yankner BA. 1992. Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol Aging 13:615-616.
91. Yankner BA, Cacere A, Duffy LK. 1990. Nerve growth factor potentiates the neurotoxicity of β amyloid. Proc Natl Acad Sci USA 87:9020-9023.
92. Zhao B, Sisodia SS, Kusiak JW. 1995. Altered processing of a mutant amyloid precursor protein in neuronal and endothelial cells. J Neurosci Res 40:261-268.
93. Zhao B, Chrest FJ, Horton WE Jr, Sisodia SS, Kusiak JW. 1997. Expression of mutant amyloid precursor protein induced apoptosis in PC12 cells. J Neurosci Res 47:253-263.